Teladoc Health, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -1.5%
EBITDA: +74.6%
EBIT: +81.9%
EPS: +83.6%
Free cash flow: +21.7%
Operating cash flow: -4.2%

Forward estimates

Revenue: +1.1%
EBITDA: —
EPS: +20.3%

Three-year CAGR

Revenue: +1.7%
EBITDA: +83.8%
EBIT: +74.2%
Net income: +80.0%
EPS: +80.6%
Free cash flow: +18.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.